Vitiligo‐like depigmentations as the first sign of melanoma: a retrospective case series from a tertiary vitiligo centre-Reference-Cited by-同舟云学术

Vitiligo‐like depigmentations as the first sign of melanoma: a retrospective case series from a tertiary vitiligo centre

Published:2016-11-11 Issue:2 Volume:176 Page:503-506
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Teulings H.E.¹,Lommerts J.E.¹,Wolkerstorfer A.¹,Nieuweboer‐Krobotova L.¹²,Luiten R.M.¹,Bekkenk M.W.¹,Veen J.P.W.¹³

Affiliation:

1. Department of Dermatology and the Netherlands Institute for Pigment Disorders (SNIP) Academic Medical Center University of Amsterdam P.O. Box 22700 Amsterdam 1100 DE the Netherlands

2. Zuwe Hofpoort Hospital Woerden the Netherlands

3. Medisch Centrum Haaglanden The Hague the Netherlands

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.14790

Reference9 articles.

1. Vitiligo and melanoma-associated hypopigmentation (MAH):shared and discriminative features

2. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study

3. Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy

4. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners

5. Vitiligo

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitiligo: From Pathogenesis to Treatment;Journal of Clinical Medicine;2024-09-03

2. Case report: Drug-induced vitiligo during treatment with BRAF/MEK inhibitors in a patient with metastatic conjunctival melanoma;Journal of Oncology Pharmacy Practice;2023-07-27

3. Vitiligo induced by immune checkpoint inhibitors in melanoma patients: an expert opinion;Expert Opinion on Drug Safety;2021-04-27

4. Metastatic Melanoma Negative for 5 Melanocytic Markers, Complete Regressed Primary Cutaneous Melanoma, and Melanoma-Associated Leukoderma in the Same Patient;The American Journal of Dermatopathology;2020-08-17

5. Melanoma to Vitiligo: The Melanocyte in Biology & Medicine–Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting;Journal of Investigative Dermatology;2020-02